Physician profile
Justin L Wright
NPI 1477753135
$484.41
in general payments reported to CMS, 2019-2025
10 companies · $62.39 in 2025
The $62.39 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.49 · 2020: $39.11 · 2021: $16.31 · 2022: $203 · 2023: $35.92 · 2024: $65.47 · 2025: $62.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $208.59 | 2020-2025 | Idosetr, Istent Infinite |
| Abbvie INC. | $67.67 | 2024-2025 | |
| Alimera Sciences, INC. | $45.69 | 2022-2023 | Yutiq |
| Sun Pharmaceutical Industries INC. | $40.14 | 2019 | |
| Bausch & Lomb Americas INC. | $33.68 | 2024-2025 | Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.35 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $17.36 | 2022 | |
| Allergan, INC. | $16.31 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.